EMA 2025 annual report: 104 human medicines recommended for marketing authorisation
A bagel you'd recommend to a friend without hedging.
Summary
EMA's 2025 annual report highlights the agency's achievements in evaluating and monitoring human and veterinary medicines. In 2025, EMA recommended 104 human medicines for marketing authorisation, including 38 with new active substances. The digital report features improved accessibility, an interactive timeline, infographics, and audio-visual materials showcasing progress in science, medicines, and health.
Key quotes
· 3 pulledEMA recommended 104 human medicines for marketing authorisation.
Of these, 38 had a new active substance which had never
The digital report includes improved accessibility features and is complemented by an interactive timeline of milestones.
You might also wanna read
EvE Bio Releases Comprehensive Dataset Mapping FDA-Approved Drugs to Cellular Receptors
EvE Bio has created a comprehensive dataset mapping interactions between approximately 1,600 FDA-approved drugs and clinically important hum
Health data of 500,000 UK Biobank participants found for sale on Alibaba
Medical details of 500,000 UK Biobank participants were discovered for sale on the Chinese e-commerce site Alibaba. The leaked data includes
Digital Markets Act causing unintended harm to European users and small businesses, critics say
The article discusses the European Union's Digital Markets Act (DMA), arguing that while intended to create fair competition in digital mark
Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure
This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont
Report Finds Hundreds of Thousands of Scam Medical Ads on Facebook
A new report reveals that Facebook is hosting hundreds of thousands of scam advertisements for medical products, including illegal or danger

ANPD Extends Deadline for Companies to Report Digital ECA Law Compliance Measures to February 2026
The Brazilian National Data Protection Authority (ANPD) has extended the deadline for companies subject to the new Digital ECA law (Law No.
